Advanced Search
Contact | Corporate | Help

A Prospective Open-Label Trial of Rituximab in Progressive Sarcoidosis

Sponsors:
  • University of Chicago
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Sarcoidosis
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Rituximab
Enrollment:
20

Additional information about NCT00552318.


SourceSolution © 2008-2012